Zhancheng Qiu

TIDE: adjuvant tislelizumab plus donafenib combined with transarterial chemoembolization for high-risk hepatocellular carcinoma after surgery: protocol for a prospective, single-arm, phase II trial

Tianfu Wen, Wei Peng, Chuan Li, 2023, Frontiers in Oncology.

Tumor burden score-AFP-albumin-bilirubin grade score predicts the survival of patients with hepatocellular carcinoma after liver resection

T. Wen, Chuan Li, S. Leng, 2023, Langenbeck's Archives of Surgery.

The application and prospection of augmented reality in hepato-pancreato-biliary surgery.

Chuan Li, Junlong Dai, Weili Qi, 2023, Bioscience trends.

Insurance status impacts survival of hepatocellular carcinoma patients after liver resection

Chuan Li, Youwei Wu, Weili Qi, 2023, Cancer medicine.

Safety of nighttime elective hepatectomy for hepatocellular carcinoma patients: a retrospective study

Weili Qi, Zhancheng Qiu, Chuan Li, 2024, Annals of surgical treatment and research.